Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Miguel Bryce

Clinical Cardiac Electrophysiology Tavares, FL Medical Doctor

NPI 1558398784 CMS profile 24734

1879 Nightingale Lane, Suite C1, Tavares, FL 32778

Open in the dashboard

General payments

$13,569

195 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Miguel Bryce of Tavares, FL is reported in the CMS Open Payments database as having received $13,569 across 195 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 41st percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,274 27
2024 General $2,655 33
2023 General $1,992 25
2022 General $1,425 24
2021 General $1,131 24
2020 General $889 21
2019 General $4,202 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Miguel Bryce
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Miguel Bryce were reported at $1,274. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Miguel Bryce Clinical Cardiac Electrophysiology median Middle half National median
2019 $4,202 $2,361 $585–$8,260 $163
2020 $889 $993 $247–$4,351 $114
2021 $1,131 $1,185 $326–$4,739 $132
2022 $1,425 $2,073 $554–$6,789 $149
2023 $1,992 $2,568 $759–$8,159 $160
2024 $2,655 $2,557 $703–$7,403 $164
2025 $1,274 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic Vascular, Inc. $4,181 45 payments
  2. Medtronic, Inc. $3,941 65 payments
  3. Abbott Laboratories $2,465 28 payments
  4. Boston Scientific Corporation $775 19 payments
  5. CVRx, Inc. $528 5 payments
  6. Impulse Dynamics (USA) Inc. $311 4 payments
  7. Kestra Medical Technology Services, Inc. $274 2 payments
  8. Respicardia, Inc. $223 2 payments
  9. Janssen Pharmaceuticals, Inc $221 7 payments
  10. Abiomed $193 2 payments
  11. Other $457 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,535 163 payments
  2. Travel and Lodging $4,966 30 payments
  3. Education $68 2 payments
Products named General payments · program years 2019–2025
  1. Reveal LINQ $2,278 21 payments
  2. AVEIR Cardiac Rhythm Management $1,226 12 payments
  3. Performa $1,148 11 payments
  4. Micra $707 17 payments
  5. Barostim Neo System $528 5 payments
  6. AVEIR Structural Heart $421 8 payments
  7. LINQ II $293 8 payments
  8. ENSITE PRECISION $281 2 payments
  9. SelectSecure $280 2 payments
  10. remede System $223 2 payments
  11. Other $4,016 93 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 37 drugs

Part D claims

2,660

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$755,298

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

40.4%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 486 $535,122
Xarelto Rivaroxaban Brand 90 $118,651
Entresto Sacubitril/Valsartan Brand 32 $47,171
Repatha Sureclick Evolocumab Brand 14 $11,379
Jardiance Empagliflozin Brand 13 $9,092
Sotalol Sotalol Hcl Brand 247 $7,156
Flecainide Acetate Generic 86 $4,535
Metoprolol Succinate Generic 289 $4,155
Rosuvastatin Calcium Generic 116 $1,685
Losartan Potassium Generic 150 $1,570

The 10 drugs with the highest cost, of 37 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 80 billing codes

Paid by Medicare

$446,454

Medicare's payments for the services billed

Medicare patients

2,104

Average age 79

Services billed

8,377

1,014 women, 1,090 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 66%
Atrial fibrillation 60%
Arthritis 57%
Chronic kidney disease 48%
Heart failure 41%
Diabetes 38%
COPD 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

195 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record